I am 32 weeks pregnant and have gestational diabetes. My doctor prescribed glyburide.
I am worried about possible effects on my baby. Can glyburide harm the baby, and can it cause fever or vomiting?
If my fasting glucose and HbA1c are within range, should I continue taking it or lower the dose? I am also concerned that my baby may develop hypoglycemia after birth. What are the chances, and does the risk depend on the glyburide dose?
Answer by Dr. Albana Greca, MD, MMedSc
Hello,
Your concern is understandable. Glyburide—also called glibenclamide—stimulates insulin release. It has been used for gestational diabetes, but current guidance generally prefers insulin when lifestyle measures are insufficient.
Yes. The original claim that glyburide does not reach the baby is incorrect. Umbilical-cord concentrations can reach about 50–70% of maternal levels.
Current ADA guidance says glyburide should not be a first-line medicine in pregnancy because it crosses the placenta, may not achieve glucose targets in everyone, and long-term safety information for exposed children is limited. Insulin remains the preferred medication because available human insulin preparations do not cross the placenta.
Yes, it may contribute. A baby can develop low glucose even when the mother's glucose is not low. Maternal hyperglycemia can stimulate the baby's pancreas to produce extra insulin, and placental exposure to glyburide may add to the risk.
There is no single percentage that predicts your baby's individual risk. In one randomized trial, neonatal hypoglycemia occurred in 12.2% of babies in the glyburide group and 7.2% in the insulin group. Other studies have reported different rates because definitions, glucose control and patient characteristics vary.
The risk may be influenced by:
No—not on your own. Normal readings may mean treatment is working. Lowering it could allow glucose to rise and increase pregnancy risks.
At the same time, repeated maternal readings below 70 mg/dL, skipped meals or symptoms such as shaking, sweating, hunger, dizziness or confusion may mean the dose needs review. Our guide to low blood glucose and hypoglycemia explains when urgent action is needed.
HbA1c is only a secondary measure during pregnancy and can miss post-meal highs or recent changes. Medication decisions should rely mainly on your fasting and after-meal pattern, symptoms, fetal growth and the treatment plan.
Do not decide by yourself when to stop glyburide. Product labels advise discontinuing glyburide before expected delivery because prolonged neonatal hypoglycemia has been reported with sulfonylurea exposure at delivery. Your team should provide the exact plan and decide whether insulin is needed.
Ask about this now. The options are explained in our gestational diabetes treatment guide.
Nausea, fullness and heartburn can occur with glyburide, although hypoglycemia is the more important safety concern. Fever is not a typical common reaction and should not automatically be blamed on the medicine.
Contact the maternity team for fever, persistent vomiting, inability to keep fluids down, abdominal pain, contractions, reduced fetal movement or repeated high or low glucose. Infection, dehydration and pregnancy complications need to be excluded.
Continue checking as prescribed. Pregnancy glucose goals are explained in our gestational diabetes monitoring overview.
Glyburide is not completely risk-free and does cross the placenta, but uncontrolled gestational diabetes also carries important risks. Do not stop or lower it based only on a normal fasting glucose or HbA1c.
Contact your obstetric or diabetes clinician promptly to review whether glyburide remains the best option at 32 weeks and to document a clear plan for the weeks before delivery and newborn glucose monitoring.
Hope this helps.
Dr. Albana Greca
Click here to post comments or follow up
Ask the Doctor now? Simply click here to return to Controlling Gestational Diabetes.